Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hematoma Block for Postoperative Pain After Femoral Intramedullary Rodding
NCT04860856Phase 4Completed
- Sponsor
- University of Cincinnati
- Start
- Aug 2019
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in Femur fracture (2 arms), sponsored by University of Cincinnati. Primary endpoint: Visual Analog Scale Pain Score at 72 hours. Started Aug 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
Femur fracture
Beyond the preview
Go deeper on NCT04860856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04860856.